11.28.23 -- Only Phase-Appropriate GMP Can Meet Clinical Supply Needs

With supply chain and transportation logistics disruptions, full documentation and complete transparency become even more important to avoid delays and assert provenance.

Clinical research involving rare disease patients raises questions about patient contact, prescreening and screening, management, and logistics. Addressing these challenges can improve outcomes.

Leveraging the expertise of a chosen clinical supply partner can be a valuable resource. Examine key considerations when partnering with a CRO in order to deliver a successful clinical supply strategy.

To build a successful decentralized clinical trial (DCT), you need to consider various factors such as in-home clinical capabilities, logistics, digital platforms, technology, and global reach.

Explore the evolvement of the clinical trial landscape over recent years, as well as the new challenges that this poses for the clinical supply chain. 

Exploring ways to eliminate barriers to enrollment and enable continued participation by bringing trials directly to patients benefits both patients and accelerates drug development.

A strong labeling team is vital to ensure successful navigation of the legal entity change process, including developing a timeline, executing data transfers, and mitigating compliance risks.

Dive into how scenario planning helps you balance risks and costs, choose the best strategy, and provide impact assessment data to stakeholders.